Related content

The Role of Peroxisome Proliferator-Activated Receptor-&ggr; in Breast Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 9, 2012-11 ,pp. : 1025-1044

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor γ ligand inhibits cell growth and invasion of human pancreatic cancer cells

By Hashimoto Koji   Ethridge Richard   Evers B.  

International Journal of Gastrointestinal Cancer, Vol. 32, Iss. 1, 2002-08 ,pp. : 7-22

Humana Press, Inc

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor γ ligand troglitazone and TRAIL synergistically induce apoptosis

By            

Oncology Reports, Vol. 31, Iss. 2, 2014-01 ,pp. : 947-954

Spandidos Publications

Access to resources Recommend Favorite

Use of the Peroxisome Proliferator-Activated Receptor (PPAR)  Ligand Troglitazone as Treatment for Refractory Breast Cancer: A Phase II Study

By Burstein H.J.  

Breast Cancer Research and Treatment, Vol. 79, Iss. 3, 2003-06 ,pp. : 391-397

Springer Publishing Company

Access to resources Recommend Favorite

Vitamin B6 regulates mRNA expression of peroxisome proliferator-activated receptor-γ target genes

By          

Experimental and Therapeutic Medicine, Vol. 2, Iss. 3, 2011-01 ,pp. : 419-424

Spandidos Publications

Access to resources Recommend Favorite